Becton Dickinson 

$201.98
681
-$1.5-0.74% 今天

統計

當日最高
203.61
當日最低
201.19
52週高點
251.99
52週低點
162.29
成交量
813,958
平均成交量
2,183,460
市值
57.65B
本益比
32.67
股息殖利率
2.06%
股息
4.17

即將到來

股息

2.06%股息殖利率
Dec 25
$1.05
Sep 25
$1.04
Jun 25
$1.04
Mar 25
$1.04
Dec 24
$1.04
10年成長
4.48%
5年成長
4.56%
3年成長
4.5%
1年成長
0.72%

財報

9Feb預期
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
下一步
2.81
3.19
3.58
3.96
預期EPS
2.8121
實際EPS
不適用

財務

7.68%利潤率
有盈利
2020
2021
2022
2023
2024
2025
43.68B營收
3.36B淨利

分析師評級

$202.67平均目標價
最高預估為 215.00。
來自過去6個月內的 6 則評分。這不是投資建議。
買入
33%
持有
67%
賣出
0%

其他人也在關注

此清單是根據在 Stock Events 上追蹤 BDX 的使用者自選建立的。這不是投資建議。

競爭對手

此清單為基於近期市場事件的分析。並非投資建議。

關於

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Show more...
執行長
Mr. Thomas E. Polen Jr.
員工
70000
國家
US
ISIN
US0758871091

上市

0 Comments

分享你的想法

FAQ

Becton Dickinson 今天的股價是多少?
BDX 目前價格為 $201.98 USD,過去 24 小時下跌了 -0.74%。在圖表上更密切關注 Becton Dickinson 股票的表現。
Becton Dickinson 的股票代號是什麼?
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Becton Dickinson 的股票以代號 BDX 進行交易。
Becton Dickinson 的股價在上漲嗎?
BDX 股票較上週下跌 -0.67%,本月上漲 +3.65%,過去一年 Becton Dickinson 下跌 -18.4%。
Becton Dickinson 的市值是多少?
今天 Becton Dickinson 的市值為 57.65B
Becton Dickinson 下一次財報日期是什麼時候?
Becton Dickinson 將於 February 09, 2026 公布下一次財報。
Becton Dickinson 上一季度的財報如何?
BDX 上一季度的財報為每股 3.96 USD,預估為 3.92 USD,帶來 +1.05% 的驚喜。下一季度的預估財報為每股 不適用 USD。
Becton Dickinson 去年的營收是多少?
Becton Dickinson 去年的營收為 43.68BUSD。
Becton Dickinson 去年的淨利是多少?
BDX 去年的淨收益為 3.36BUSD。
Becton Dickinson 會發放股息嗎?
是的,BDX 的股息每 每季 發放一次。每股最新股息為 1.05 USD。截至今日,股息殖利率(FWD)% 為 2.06%。
Becton Dickinson 有多少名員工?
截至 February 02, 2026,公司共有 70,000 名員工。
Becton Dickinson 位於哪個產業?
Becton Dickinson從事於Health Care產業。
Becton Dickinson 何時完成拆股?
Becton Dickinson 最近沒有進行任何拆股。
Becton Dickinson 的總部在哪裡?
Becton Dickinson 的總部位於 US 的 Franklin Lakes。